A scientist with a breakthrough therapy shouldn't lose a Series A to a competitor with a louder LinkedIn presence. But it happens every quarter. That's the problem we built Bioverse to solve.
Bioverse was founded because we kept seeing the same story: a brilliant biotech founder, a real scientific breakthrough, and a fundraising round that fell apart because the wrong investors heard about it too late.
Meanwhile, a generic competitor — with mid-tier science but excellent positioning — closed the round.
This isn't a marketing problem. It's a survival problem. The biotech ecosystem rewards the visible, not always the brilliant. We exist to make sure the brilliant become the visible.
Most agencies say they "specialize" in everything. We mean it: we only work with biotech, life sciences, and healthcare innovators. That's why we can speak the language of your investors, partners, and KOLs without translation.
We turn down B2B SaaS, e-commerce, and consumer brands every week. Our entire workflow, vocabulary, and team is engineered for life sciences. No translation tax.
Every service has defined inputs, outputs, and timelines. You know exactly what you're paying for. No "discovery phases" that consume budget without producing assets.
We measure investor inbounds, partnership conversations, talent applications. Not impressions. Not vanity metrics. The numbers your board actually cares about.
Your founder is the brand. We protect their voice, their scientific integrity, and their time. We write what they would write if they had eight more hours each week.
While other agencies are still optimizing for Google 2018, we're optimizing for ChatGPT, Perplexity, and Google AI Overviews. The next 5 years of investor research happens here.
Every post, page, and paper we ship makes the next one work harder. Authority compounds. Visibility compounds. Investor trust compounds. That's the entire game.
We're selective. If you fit one of these profiles, we'd love to talk. If you don't, we'll happily refer you elsewhere.
You've raised institutional capital, you have real science, and you need to convert that into the next round, partnership, or commercial milestone within 12–18 months.
You sell into clinicians, hospitals, or labs. Your buyers are highly technical, and your sales cycle is long. You need authority assets that compound trust over months.
You serve other biotech and pharma companies. Your buyers research extensively before they ever take a call. You need to be the first name they encounter.
No pitch deck. No sales pressure. Just a candid conversation about your stage, your goals, and whether Bioverse is the right fit. We'll tell you honestly either way.